help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imagawa, W.
Right arrow Articles by Nandi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imagawa, W.
Right arrow Articles by Nandi, S.

Endocrinology, Vol 119, 2695-2699, Copyright © 1986 by Endocrine Society


ARTICLES

Somatomedin-C substitutes for insulin for the growth of mammary epithelial cells from normal virgin mice in serum-free collagen gel cell culture

W Imagawa, EM Spencer, L Larson and S Nandi

We investigated the effect of somatomedin C (SM-C) on the growth of mouse mammary ductal epithelial cells in collagen gel culture. Epithelial cells, isolated by collagenase digestion of whole glands, were placed into primary serum-free collagen gel cell culture for 10-12 days, during which SM-C was added alone or in combination with other growth-promoting factors. Previous work has shown that these cells require a superphysiological concentration of insulin (10 micrograms/ml) for optimum growth in serum-free medium (a 1:1 mixture of Ham's F-12 and Dulbecco's Modified Eagle's medium) containing epidermal growth factor (EGF). When SM-C (1-250 ng/ml) alone was added to serum-free basal medium containing EGF, it stimulated growth (at concentrations greater than 25 ng/ml) to at least the same extent as insulin at 10 micrograms/ml. There was no additive stimulation of growth when optimal concentrations of insulin and SM-C were added together. The nonadditive stimulation at optimal concentrations of these hormones may indicate that the previous requirement for a superphysiological concentration of insulin for maximum growth was due to low affinity binding of insulin to the SM-C receptor. Rat insulin- like growth factor II (Collaborative Research) at 50-200 ng/ml did not stimulate growth in the presence or absence of insulin. SM-C could not stimulate growth alone. The presence of EGF or mammogenic hormones (progesterone and PRL) was required.


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. V. Loladze, M. A. Stull, A. M. Rowzee, J. DeMarco, J. H. Lantry III, C. J. Rosen, D. LeRoith, K.-U. Wagner, L. Hennighausen, and T. L. Wood
Epithelial-Specific and Stage-Specific Functions of Insulin-Like Growth Factor-I during Postnatal Mammary Development
Endocrinology, November 1, 2006; 147(11): 5412 - 5423.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H.-Z. Zhang, J. M. Bennett, K. T. Smith, N. Sunil, and S. Z. Haslam
Estrogen Mediates Mammary Epithelial Cell Proliferation in Serum-Free Culture Indirectly via Mammary Stroma-Derived Hepatocyte Growth Factor
Endocrinology, September 1, 2002; 143(9): 3427 - 3434.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Sunil, J. M. Bennett, and S. Z. Haslam
Hepatocyte Growth Factor Is Required for Progestin-Induced Epithelial Cell Proliferation and Alveolar-Like Morphogenesis in Serum-Free Culture of Normal Mammary Epithelial Cells
Endocrinology, August 1, 2002; 143(8): 2953 - 2960.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. A. Stull, M. M. Richert, A. V. Loladze, and T. L. Wood
Requirement for IGF-I in Epidermal Growth Factor-Mediated Cell Cycle Progression of Mammary Epithelial Cells
Endocrinology, May 1, 2002; 143(5): 1872 - 1879.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Xing and W. Imagawa
Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF
Carcinogenesis, July 1, 1999; 20(7): 1201 - 1208.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. M. Richert and T. L. Wood
The Insulin-Like Growth Factors (IGF) and IGF Type I Receptor during Postnatal Growth of the Murine Mammary Gland: Sites of Messenger Ribonucleic Acid Expression and Potential Functions
Endocrinology, January 1, 1999; 140(1): 454 - 461.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society